Promoting effects of chemical permeation enhancers on insulin permeation across TR146 cell model of buccal epithelium in vitro

References

• Bernkop-Schnurch, A., Kast, C. E., Guggi, D. (2003). Permeation enhancing polymers in oral delivery of hydrophilic macromolecules: thiomer/GSH systems. J Contr Rel 93:95–103.
   PubMed Web of Science ®Google Scholar
• Bernstein, G. (2008). Delivery of insulin to the buccal mucosa utilizing the RapidMist system. Exp Opin Drug Deliv 5:1047–1055.
   PubMed Web of Science ®Google Scholar
• Bruttomesso, D., Costa, S., Baritussio, A. (2009). Continuous subcutaneous insulin infusion (CSII) 30 years later: still the best option for insulin therapy. Diab Metab Res Rev 25:99–111.
   PubMed Web of Science ®Google Scholar
• Cernea, S., Raz, I. (2006). Noninjectable methods of insulin administration. Timely Top Med Cardiovasc Dis 10:E29.
   PubMedGoogle Scholar
• Dhiman, M. K., Dhiman, A., Sawant, K. K. (2009). Transbuccal delivery of 5-fluorouracil: permeation enhancement and pharmacokinetic study. AAPS PharmSciTech 10:258–265.
   PubMed Web of Science ®Google Scholar
• Fetih, G., Habib, F., Okada, N., Fujita, T., Attia, M., Yamamoto, A. (2005). Nitric oxide donors can enhance the intestinal transport and absorption of insulin and [Asu(1,7)]-eel calcitonin in rats. J Contr Rel 106:287–297.
   PubMed Web of Science ®Google Scholar
• Hassan, N., Ahad, A., Ali, M., Ali, J. (2010). Chemical permeation enhancers for transbuccal drug delivery. Exp Opin Drug Deliv 7:97–112.
   PubMed Web of Science ®Google Scholar
• Hoyer, H., Foger, F., Kafedjiiski, K., Loretz, B., Bernkop-Schnurch, A. (2007). Design and evaluation of a new gastrointestinal mucoadhesive patch system containing chitosan-glutathione. Drug Dev Ind Pharm 33:1289–1296.
   PubMed Web of Science ®Google Scholar
• Jacobsen, J., Pedersen, M., Rassing, M. R. (1996). TR146 cells as a model for human buccal epithelium: II. Optimisation and use of a cellular sensitivity MTS/PMS assay. Int J Pharmaceut 141:217–225.
   Web of Science ®Google Scholar
• Jacobsen, J., Van Deurs, B., Pedersen, M., Rassing, M. R. (1995). TR146 cells grown on filters as a model for human buccal epithelium. I: Morphology, growth, barrier properties, and permeability. Int J Pharmaceut 125:165–184.
   Web of Science ®Google Scholar
• Kirjavainen, M., Monkkonen, J., Saukkosaari, M., Valjakka-Koskela, R., Kiesvaara, J., Urtti, A. (1999). Phospholipids affect stratum corneum lipid bilayer fluidity and drug partitioning into the bilayers. J Contr Rel 58:207–214.
   PubMed Web of Science ®Google Scholar
• Kulkarni, U., Mahalingam, R., Pather, I., Li, X., Jasti, B. (2010). Porcine buccal mucosa as in vitro model: effect of biological and experimental variables. J Pharm Sci 99:1265–1277.
   PubMed Web of Science ®Google Scholar
• Kulkarni, U., Mahalingam, R., Pather, S. I., Li, X., Jasti, B. (2009). Porcine buccal mucosa as an in vitro model: relative contribution of epithelium and connective tissue as permeability barriers. J Pharm Sci 98:471–483.
   PubMed Web of Science ®Google Scholar
• Langoth, N., Bernkop-Schnurch, A., Kurka, P. (2005). In vitro evaluation of various buccal permeation enhancing systems for PACAP (pituitary adenylate cyclase-activating polypeptide). Pharm Res 22:2045–2050.
   PubMed Web of Science ®Google Scholar
• Lassmann-Vague, V., Raccah, D. (2006). Alternatives routes of insulin delivery. Diab Metab 32:513–522.
   PubMed Web of Science ®Google Scholar
• Longbottom, D., Sallenave, J. M., van Heyningen, V. (1992). Subunit structure of calgranulins A and B obtained from sputum, plasma, granulocytes, and cultured epithelial cells. Biochim Biophys Acta 1120:215–222.
   PubMed Web of Science ®Google Scholar
• Matsuyama, T., Morita, T., Horikiri, Y., Yamahara, H., Yoshino, H. (2006). Improved nasal absorption of salmon calcitonin by powdery formulation with N-acetyl-L-cysteine as a mucolytic agent. J Contr Rel 115:183–188.
   PubMed Web of Science ®Google Scholar
• Morck Nielsen, H., Romer Rassing, M. (2000). TR146 cells grown on filters as a model of human buccal epithelium: V. Enzyme activity of the TR146 cell culture model, human buccal epithelium and porcine buccal epithelium, and permeability of leu-enkephalin. Int J Pharm 200:261–270.
   PubMedGoogle Scholar
• Morimoto, K., Yamaguchi, H., Iwakura, Y., Miyazaki, M., Nakatani, E., Iwamoto, T., et al. (1991). Effects of proteolytic enzyme inhibitors on the nasal absorption of vasopressin and an analogue. Pharm Res 8:1175–1179.
   PubMed Web of Science ®Google Scholar
• Murakami, M., Takada, K., Fujii, T., Muranishi, S. (1988). Intestinal absorption enhanced by unsaturated fatty acids: inhibitory effect of sulfhydryl modifiers. Biochim Biophys Acta 939:238–246.
   PubMed Web of Science ®Google Scholar
• Nicolazzo, J. A., Reed, B. L., Finnin, B. C. (2005). Enhanced buccal mucosal retention and reduced buccal permeability of estradiol in the presence of padimate O and Azone: a mechanistic study. J Pharm Sci 94:873–882.
   PubMed Web of Science ®Google Scholar
• Nielsen, H. M., Rassing, M. R. (1999). TR146 cells grown on filters as a model of human buccal epithelium: III. Permeability enhancement by different pH values, different osmolality values, and bile salts. Int J Pharm 185:215–225.
   PubMed Web of Science ®Google Scholar
• Nielsen, H. M., Rassing, M. R. (2000). TR146 cells grown on filters as a model of human buccal epithelium: IV. Permeability of water, mannitol, testosterone, and beta-adrenoceptor antagonists. Comparison to human, monkey, and porcine buccal mucosa. Int J Pharm 194:155–167.
   Google Scholar
• Nielsen, H. M., Rassing, M. R. (2002). Nicotine permeability across the buccal TR146 cell culture model and porcine buccal mucosa in vitro: effect of pH and concentration. Eur J Pharm Sci 16:151–157.
   PubMed Web of Science ®Google Scholar
• Portero, A., Remunan-Lopez, C., Nielsen, H. M. (2002). The potential of chitosan in enhancing peptide and protein absorption across the TR146 cell culture model—an in vitro model of the buccal epithelium. Pharm Res 19:169–174.
   PubMed Web of Science ®Google Scholar
• Pouwer, F., Hermanns, N. (2009). Insulin therapy and quality of life. A review. Diab Metab Res Rev 25(Suppl 1):S4–S10.
   Google Scholar
• Rossi, S., Sandri, G., Caramella, C. M. (2005). Buccal drug delivery: a challenge already won? Drug Discov Today Technol 2:59–65.
   PubMedGoogle Scholar
• Senel, S., Hincal, A. A. (2001). Drug permeation enhancement via buccal route: possibilities and limitations. J Contr Rel 72:133–144.
   PubMed Web of Science ®Google Scholar
• Shaikh, I. M., Jadhav, K. R., Ganga, S., Kadam, V. J., Pisal, S. S. (2005). Advanced approaches in insulin delivery. Curr Pharm Biotechnol 6:387–395.
   PubMed Web of Science ®Google Scholar
• Sohi, H., Ahuja, A., Ahmad, F. J., Khar, R. K. (2009). Critical evaluation of permeation enhancers for oral mucosal drug delivery. Drug Dev Ind Pharm 36:254–282.
   Web of Science ®Google Scholar
• Squier, C. A., Rooney, L. (1976). The permeability of keratinized and nonkeratinized oral epithelium to lanthanum in vivo. J Ultrastruct Res 54:286–295.
   PubMedGoogle Scholar
• Sudhakar, Y., Kuotsu, K., Bandyopadhyay, A. K. (2006). Buccal bioadhesive drug delivery—a promising option for orally less efficient drugs. J Contr Rel 114:15–40.
   PubMed Web of Science ®Google Scholar
• Walker, G. F., Langoth, N., Bernkop-Schnurch, A. (2002). Peptidase activity on the surface of the porcine buccal mucosa. Int J Pharm 233:141–147.
   PubMed Web of Science ®Google Scholar
• Wang, X., Zheng, C., Wu, Z., Teng, D., Zhang, X., Wang, Z., et al. (2009). Chitosan-NAC nanoparticles as a vehicle for nasal absorption enhancement of insulin. J Biomed Mater Res B Appl Biomater 88:150–161.
   PubMed Web of Science ®Google Scholar
• Yu, D., Gao, Q., Sheng, X., Gu, X. (2004). [Quantitative determination of insulin in microemulsion preparations by RP-HPLC]. Se Pu 22:294.
   PubMedGoogle Scholar